• 1. Dyson DHJames-Davies R. Dose effects and benefits of glycopyrrolate in the treatment of bradycardia in anesthetized dogs. Can Vet J 1999;40:321331.

    • Search Google Scholar
    • Export Citation
  • 2. Hendrix PKRobinson EP. Effects of a selective and nonselective muscarinic cholinergic antagonist on heart rate and intestinal motility in dogs. J Vet Pharmacol Ther 1997;20:387395.

    • Search Google Scholar
    • Export Citation
  • 3. Kantelip JPAlatienne MGueorguiev G, et al. Chronotropic and dromotropic effects of atropine and hyoscine methobromide in unanesthetized dogs. Br J Anaesth 1985;57:214219.

    • Search Google Scholar
    • Export Citation
  • 4. Richards DLClutton REBoyd C. Electrocardiographic findings following intravenous glycopyrrolate to sedated dogs: a comparison with atropine. Vet Anaesth Analg 1989;16:4650.

    • Search Google Scholar
    • Export Citation
  • 5. Muir WW. Effects of atropine on cardiac rate and rhythm in dogs. J Am Vet Med Assoc 1978;172:917921.

  • 6. Dyson DHPascoe PJMcDonnel WN. Effects of intravenously administered glycopyrrolate in anesthetized horses. Can Vet J 1999;40:2932.

    • Search Google Scholar
    • Export Citation
  • 7. Lemke KA. Electrocardiographic and cardiopulmonary effects of intramuscular administration of glycopyrrolate and romifidine in conscious Beagles. Vet Anaesth Analg 2001;28:7586.

    • Search Google Scholar
    • Export Citation
  • 8. Wessler IKirkpatrick CJ. Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans. Br J Pharmacol 2008;154:15581571.

    • Search Google Scholar
    • Export Citation
  • 9. Haddad EMPatel HKeeling JE, et al. Pharmacological characterization of the muscarinic receptor antagonist, glycopyrrolate, in human and guinea-pig airways. Br J Pharmacol 1999;127:413420.

    • Search Google Scholar
    • Export Citation
  • 10. Mirkhur RKDundee JW. Comparison of the effects of atropine and glycopyrrolate on various end-organs. J R Soc Med 1980;73:727730.

    • Search Google Scholar
    • Export Citation
  • 11. Karhunen UCozanitis DABrander P. The oculocardiac reflex in adults. A dose response study of glycopyrrolate and atropine. Anesthesia 1984;39:524528.

    • Search Google Scholar
    • Export Citation
  • 12. Roush JKKeene BWWicker SW, et al. Effects of atropine and glycopyrrolate on esophageal, gastric, and tracheal pH in anesthetized dogs. Vet Surg 1990;19:8892.

    • Search Google Scholar
    • Export Citation
  • 13. Singh SMcDonell WNYoung SS, et al. The effect of glycopyrrolate on heart rate and intestinal motility in conscious horses. J Vet Anesth 1997;24:1419.

    • Search Google Scholar
    • Export Citation
  • 14. Ludders JWHeavner JE. Effects of atropine on tear formation in anesthetized dogs. J Am Vet Med Assoc 1979;175:585586.

  • 15. Arnett BDBrightman AHMusselmann EE. Effects of atropine sulfate on tear production in the cat when used with ketamine hydrochloride and acetylpromazine maleate. J Am Vet Med Assoc 1984;185:214215.

    • Search Google Scholar
    • Export Citation
  • 16. Vestre WABrightman AHHelper LC, et al. Decreased tear production associated with general anesthesia in the dog. J Am Vet Med Assoc 1979;174:10061007.

    • Search Google Scholar
    • Export Citation
  • 17. Herring IPPickett JPChampagne ES, et al. Evaluation of aqueous tear production in dogs following general anesthesia. J Am Anim Hosp Assoc 2000;36:427430.

    • Search Google Scholar
    • Export Citation
  • 18. Das G. Therapeutic review: cardiac effects of atropine in man: an update. Int J Clin Pharmacol Ther Toxicol 1989;27:473477.

  • 19. Hollingsworth SRCanton DDBuyukmihci NC, et al. Effect of topically administered atropine on tear production in dogs. J Am Vet Med Assoc 1992;200:14811484.

    • Search Google Scholar
    • Export Citation
  • 20. The Association for Research in Vision and Ophthalmology. Statement for the use of animals in ophthalmic and visual research. Available at: www.arvo.org/about_arvo/policies/statement_for_the_use_of_animals_in_ophthalmic_and_visual_research/. Accessed Jan 13, 2016.

    • Search Google Scholar
    • Export Citation
  • 21. Hamor RERoberts SMSeverin GA, et al. Evaluation of results of Schirmer tear tests conducted with and without application of a topical anesthetic in clinically normal dogs of 5 breeds. Am J Vet Res 2000;61:14221452.

    • Search Google Scholar
    • Export Citation
  • 22. Saito AKotani T. Tear production in dogs with epiphora and corneal epitheliopathy. Vet Ophthalmol 1999;2:173178.

  • 23. Wyman MGilger BMueller P, et al. Clinical evaluation of a new Schirmer tear test in the dog. Vet Comp Ophthalmol 1995;5:211214.

    • Search Google Scholar
    • Export Citation
  • 24. Hirsh SGKaswan RL. A comparative study of Schirmer tear test strips in dogs. Vet Comp Ophthalmol 1995;5:215217.

  • 25. Lemke KA. Electrocardiographic and cardiopulmonary effects of intramuscular administration of glycopyrrolate and romifidine in conscious Beagle dogs. Vet Anaesth Analg 2001;28:7586.

    • Search Google Scholar
    • Export Citation
  • 25. Fazio DTBateman JBChristensen RE. Acute angle-closure glaucoma associated with surgical anesthesia. Arch Ophthalmol 1985;103:360362.

    • Search Google Scholar
    • Export Citation
  • 26. Jaroudi MFadi MFadi F, et al. Glycopyrrolate induced bilateral angle closure glaucoma after cervical spine surgery. Middle East Afr J Ophthalmol 2013;20:182184.

    • Search Google Scholar
    • Export Citation
  • 27. Frischmeyer KJMiller PEBellary Y, et al. Parenteral anticholinergic in dogs with normal and elevated intraocular pressure. Vet Surg 1993;22:230234.

    • Search Google Scholar
    • Export Citation

Advertisement

Effects of intramuscular injection of glycopyrrolate on Schirmer tear test I results in dogs

View More View Less
  • 1 Eye Care For Animals, 175 E Fort Lowell Rd, Tucson, AZ 85705.
  • | 2 Southwest Veterinary Anesthesiology, 175 E Fort Lowell Rd, Tucson, AZ 85705.
  • | 3 Eye Care For Animals, 175 E Fort Lowell Rd, Tucson, AZ 85705.

Abstract

OBJECTIVE To determine effects of glycopyrrolate administered IM on Schirmer tear test I (STT I) measurements in dogs.

DESIGN Prospective clinical study.

ANIMALS 13 client- and staff-owned dogs.

PROCEDURES For both eyes of each dog, STT I measurements were recorded twice 20 minutes apart (at T1 and T2) and 2 to 4 hours later (at T3). Glycopyrrolate (0.01 mg/kg [0.005 mg/lb]) was administered IM to all dogs (3 dogs received an injection of saline [0.9% NaCl] solution on an earlier occasion), and final STT I measurements were recorded 20 minutes later (at T4). Intraocular pressures, heart rate, and respiratory rate were also recorded at each time point.

RESULTS Ophthalmic variables did not differ between right and left eyes. In all dogs, variables at T1, T2, or T3 (measurements before glycopyrrolate administration) did not differ; baseline values were therefore defined at T3. At T4, STT I measurements were significantly decreased (mean ± SD decrease, 67.4 ± 15.4% [mean actual decrease, 15.8 mm/min]). During the same period, mean heart rate increased by 26.5 ± 12.0% (mean actual increase, 30.2 beats/min). Glycopyrrolate had no effect on intraocular pressure or respiratory rate. In 5 dogs at 24 hours after glycopyrrolate treatment, STT I measurement in each eye had returned to baseline value. Saline solution treatment (3 dogs) had no effect on any variables.

CONCLUSIONS AND CLINICAL RELEVANCE In dogs, IM injection of glycopyrrolate resulted in a clinically relevant transient decrease in aqueous tear production. Application of lacrimomimetics beginning at the time of or within 20 minutes after glycopyrrolate premedication is recommended until STT I measurements return to baseline.

Contributor Notes

Address correspondence to Dr. Doering (cdoering@eyecareforanimals.com).